Cargando…
Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide. Atherosclerosis is the most common form of CVD, which is complex and multifactorial with an elevated risk observed in people with either metabolic or inflammatory diseases. Accumulating evidence now links obesity with a s...
Autores principales: | Kraakman, Michael J, Dragoljevic, Dragana, Kammoun, Helene L, Murphy, Andrew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910124/ https://www.ncbi.nlm.nih.gov/pubmed/27350883 http://dx.doi.org/10.1038/cti.2016.31 |
Ejemplares similares
-
Inhibition of interleukin‐1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis
por: Dragoljevic, Dragana, et al.
Publicado: (2020) -
Cholesterol Efflux Pathways Regulate Myelopoiesis: A Potential Link to Altered Macrophage Function in Atherosclerosis
por: Murphy, Andrew James, et al.
Publicado: (2014) -
Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome
por: Kraakman, Michael J., et al.
Publicado: (2018) -
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
por: Veiga, Camilla Bertuzzo, et al.
Publicado: (2021) -
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis
por: Dragoljevic, Dragana, et al.
Publicado: (2023)